Xometry (XMTR) | News Based Sentiment Analysis

• On October 1, 2025, Xometry reported a strong second quarter, with revenue reaching $162.55 million – a 22.6% increase year-over-year and exceeding analyst expectations of $156.53 million. Despite this positive performance, the stock price declined 4.3% on October 1st, closing at $52.10, which suggests investor reaction wasn't entirely positive despite the earnings beat.
• Following the Q2 earnings report, CFO James Miln sold 598 shares of Xometry stock on September 2nd at an average price of $50.25, totaling $30,049.50, decreasing his ownership by 0.41%. A further planned sale of 598 shares, valued at $32,196, was indicated in a Form 144 filing on October 1st, 2025, raising questions about insider confidence.
• CEO Randolph Altschuler also participated in stock sales, selling 9,331 shares on October 2, 2025, for $469,442.61, reducing his direct ownership by 2.92%. These sales, conducted under a Rule 10b5-1 plan, alongside tax withholding sales, contributed to a slight increase in the share price on October 3rd, reaching $51.52.
• Despite insider selling, Xometry is receiving positive attention from analysts, with StockInvest.us upgrading its analysis to a "Buy" candidate on October 3, 2025, projecting potential price increases. Zacks Investment Research also identified Xometry as a "Top Momentum Pick" on October 2, 2025, assigning a Zacks Rank of #2 (Buy) and a Momentum Style Score of "B".
• Earnings estimates for Xometry have been revised upward over the past two months, with no downgrades, and Simply Wall St's DCF model estimates a fair value of $64.68, implying the stock is approximately 20% "Undervalued" at its current trading price of $50.26 as of October 5, 2025. However, Simply Wall St's consensus narrative sets a fair value of $47.67, suggesting the stock might be "OVERVALUED".
• Xometry is actively expanding internationally, seeking a Vice President of International Partner Network to lead expansion across China, Europe, and Turkey, announced on October 2, 2025. This strategic move aims to enhance their global supply base and improve customer order fulfillment.

The Investment Story: October was a month of contrasts for Xometry, marked by a strong Q2 earnings report alongside notable insider selling. While analysts are increasingly optimistic, the market's initial reaction to the earnings and insider activity suggests caution is warranted.

What It Means for Investors: The earnings beat is encouraging, but the stock's decline and insider sales create a mixed picture. The upward revisions in earnings estimates and positive analyst ratings offer some support, but investors should closely monitor trading volume and insider activity.

Looking Ahead: Investors should watch for Q3 2025 earnings and monitor the progress of the international partner network expansion. Further insider trading activity and any shifts in analyst sentiment will also be crucial indicators.

The Bottom Line: Xometry presents a complex investment opportunity. The company is demonstrating financial improvement and pursuing strategic growth, but recent stock performance and insider activity suggest potential headwinds. A cautious approach, focused on monitoring key metrics and upcoming catalysts, is recommended.